Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT
Nektar Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.18M | 10.46M | 29.18M | 24.12M | 23.49M | 21.64M | 23.89M | 24.14M | 20.5M | 21.59M | 22.02M | 23.63M | 21.59M | 24.82M | 25.01M | 24.92M | 28.33M | 23.65M |
Cost of Revenue | 214K | 426K | 7.98M | 4.43M | 9.74M | 8.53M | 7.28M | 12.43M | 6.99M | 7.06M | 6.23M | 4.97M | 5.12M | 5.32M | 6.16M | 5.31M | 7.67M | 5.76M |
Gross Profit | 10.96M | 10.46M | 21.2M | 19.69M | 13.75M | 13.11M | 16.6M | 11.71M | 13.51M | 14.53M | 15.79M | 18.65M | 16.47M | 19.51M | 18.85M | 19.61M | 20.66M | 17.89M |
Operating Income | -36.23M | -44.53M | 14.35M | -34.34M | -49.77M | -35.43M | 92.75M | -33.5M | -50.6M | -134.71M | -40.89M | -37.47M | -46.79M | -115.08M | -112.91M | -113.6M | -110.2M | -109.39M |
Interest Income | 1.97M | 2.87M | 2.94M | 3.44M | 3.9M | 4.22M | 4.95M | 4.88M | 4.85M | 4.33M | 3.13M | 2.05M | 1.1M | 395K | 181K | 131K | 845K | 1.41M |
Pretax Income | -39.4M | -46.37M | 7M | -37.05M | -52.32M | -36.84M | -42.11M | -45.9M | -51.17M | -137.08M | -56.54M | -59.2M | -158.97M | -90.27M | -145.65M | -129.59M | -125.16M | -122.88M |
Net Income | -41.59M | -50.88M | 7.26M | -37.06M | -52.36M | -36.8M | -42.08M | -45.84M | -51.12M | -137.02M | -59.69M | -59.05M | -159.07M | -90.39M | -145.65M | -129.71M | -125.52M | -122.97M |
Selling & General & Admin | 17.07M | 24.35M | 17.14M | 18.96M | 20.51M | 20.15M | 17.32M | 21.15M | 17.87M | 21.08M | 21.94M | 22.53M | 20.52M | 27.34M | 32.14M | 29.47M | 29.55M | 31.68M |
Research & Development | 29.89M | 30.48M | 28.75M | 35.03M | 29.72M | 27.41M | 29.94M | 24.07M | 29.68M | 30.47M | 34.74M | 33.59M | 42.74M | 107.25M | 99.61M | 103.74M | 101.31M | 95.6M |
Other Expenses | n/a | 169K | -39.03M | 46K | 13.29M | 975K | n/a | 11.36M | n/a | 97.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 46.96M | 54.99M | 6.85M | 54.03M | 63.52M | 48.53M | 47.26M | 56.58M | 47.55M | 149.24M | 56.68M | 56.12M | 63.26M | 134.59M | 131.76M | 133.21M | 130.87M | 127.28M |
Interest Expense | 5.39M | 4.97M | 10.15M | 6.02M | 6.41M | 5.53M | 6.87M | 5.91M | 6.15M | 6.41M | 7.2M | 6.95M | 7.23M | 7.53M | 8.13M | 12.8M | 13.09M | 13.3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.41M | 54.99M | 14.83M | 58.47M | 73.26M | 57.07M | 54.55M | 69.01M | 54.54M | 156.3M | 62.91M | 61.1M | 68.38M | 139.91M | 137.92M | 138.52M | 138.53M | 133.04M |
Income Tax Expense | -188K | 52K | -259K | 9K | 46K | -35K | -29K | -61K | -47K | -63K | 3.14M | -155K | 100K | 126K | -4K | 112K | 357K | 92K |
Shares Outstanding (Basic) | 14.09M | 14.06M | 13.98M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M | 12.59M | 12.55M | 12.51M | 12.45M | 12.39M | 12.33M | 12.27M | 12.18M | 12.09M |
Shares Outstanding (Diluted) | 14.09M | 14.06M | 14.24M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M | 12.59M | 12.55M | 12.51M | 12.45M | 12.39M | 12.33M | 12.27M | 12.18M | 12.09M |
EPS (Basic) | -2.95 | -3.62 | 0.52 | -2.66 | -3.76 | -2.83 | -3.3 | -3.61 | -4.05 | -10.95 | -4.8 | -4.65 | -12.75 | -7.35 | -11.85 | -10.5 | -10.35 | -10.2 |
EPS (Diluted) | -2.95 | -3.62 | 0.51 | -2.66 | -3.76 | -2.83 | -3.3 | -3.61 | -4.05 | -10.95 | -4.8 | -4.65 | -12.75 | -7.35 | -11.85 | -10.5 | -10.35 | -10.2 |
EBITDA | -36.23M | -40.97M | 17.49M | -30.04M | -44.45M | -29.7M | -33.59M | -38.29M | -42.85M | -128.37M | -37.76M | -49.57M | -148.3M | -79.01M | -135.23M | -113.17M | -108.53M | -106.04M |
EBIT | -34M | -41.4M | 17.16M | -31.03M | -45.91M | -31.31M | -35.24M | -39.99M | -45.02M | -130.68M | -49.34M | -52.25M | -151.74M | -82.74M | -137.52M | -116.79M | -112.07M | -109.58M |
Depreciation & Amortization | 214K | 426K | 332K | 993K | 1.46M | 1.61M | 1.65M | 1.7M | 2.17M | 2.3M | 2.35M | 2.68M | 3.44M | 3.73M | 2.29M | 3.62M | 3.55M | 3.54M |